Related Experiment Videos

Calcium blockade in arterial hypertension. Review

Insights

Calcium channel blockers effectively lower blood pressure in hypertension. While generally safe, nifedipine may require combination therapy due to tolerance, and long-term human benefits on cardiovascular structure need further study.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Arterial hypertension involves altered calcium (Ca++) roles in vascular smooth muscle.
  • Calcium channel blockers exhibit enhanced vasodilatory effects in hypertensive individuals.

Purpose of the Study:

  • To evaluate the efficacy and side effects of calcium channel blockers in managing arterial hypertension.
  • To compare the acute and chronic effects of verapamil and nifedipine.

Main Methods:

  • Acute and chronic administration of calcium channel blockers (verapamil, nifedipine).
  • Monitoring of blood pressure, heart rate, plasma renin activity, and catecholamines.
  • Assessment of diuretic, natriuretic, and uricosuric effects.

Main Results:

  • Both verapamil and nifedipine reduce blood pressure acutely and chronically.
  • Nifedipine causes more pronounced reflex increases in heart rate and catecholamines compared to verapamil.
  • Acute diuretic, natriuretic, and uricosuric effects were observed.
  • Tolerance to nifedipine develops with repeated administration, potentially requiring combination therapy.

Conclusions:

  • Calcium channel blockers are effective antihypertensive agents.
  • Nifedipine's long-term use may necessitate combination with other drugs like beta-blockers and diuretics.
  • While animal studies show benefits on hypertensive cardiovascular changes, human data are still needed.

Related Concept Videos